Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn’s disease
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Chronic inflammation in inflammatory bowel disease (IBD; Crohn's disease and ulcerative colitis) may be attributed partly to increased secretion of inflammatory cytokines. The aim of this study was to investigate simultaneously the spontaneous release patterns of tumor necrosis factor-alpha (TNF-alpha), interleukin-1-beta (IL-1 beta), and interleukin-6 (IL-6) by organ cultures of inflamed mucosa from IBD patients. Organ cultures of involved IBD mucosa spontaneously produced increased amounts of TNF-alpha, IL-1 beta, and IL-6 compared to normal mucosa. The patterns of cytokine release between Crohn's disease and ulcerative colitis organ cultures were not significantly different. Increased inflammatory cytokine production by lamina propria mononuclear cells (LPMCs) and mucosa treated with EDTA suggests that these cytokines originate mainly from LPMCs. These results confirm the role of inflammatory cytokines in IBD and shed a new light on the role of TNF-alpha in IBD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“that are necessary and sufficient to induce villus injury and compromise intestinal barrier function.”
From Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip (2016) · cites this paper as [40]
In the citing paper
“The same cytokines have been reported to be up-regulated in clinical studies of human inflammatory diseases, including in patients with active ulcerative colitis patients (41), Crohn's disease (40), and pouchitis (42).”
From Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip (2016) · cites this paper as [40]
Citations
Cites
Cortisone in Ulcerative Colitis
Truelove, S. C., & Witts, L. J. (1955) · BMJ · doi:10.1136/bmj.2.4947.1041 · Cited by 2,767
Powrie, F., Leach, M. W., Mauze, S., Menon, S., Barcomb Caddle, L., & Coffman, R. L. (1994) · Immunity · doi:10.1016/1074-7613(94)90045-0 · Cited by 1,146 · cited 2×
“However, long-term effectiveness of anti-TNF-a antibodies required continuous administration of the antibody (16, 17 ).”
BackgroundTreatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
van Dullemen, H. M., van Deventer, S. J. H., Hommes, D. W., Bijl, H. A., Jansen, J., Tytgat, G. N. J., & Woody, J. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90277-5 · Cited by 1,084
REINECKER, H.-C., STEFFEN, M., WITTHOEFT, T., PFLUEGER, I., SCHREIBER, S., MacDERMOTT, R. P., & RAEDLER, A. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb05997.x · Cited by 856
Powrie, F., Correa-Oliveira, R., Mauze, S., & Coffman, R. L. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.589 · Cited by 613
Breese, E. J., Michie, C. A., Nicholls, S. W., Murch, S. H., Williams, C. B., Domizio, P., Walker-Smith, J. A., & Macdonald, T. T. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90398-0 · Cited by 566
Microscopic activity in ulcerative colitis: what does it mean?
Riley, S. A., Mani, V, Goodman, M. J., Dutt, S., & Herd, M. E. (1991) · Gut · doi:10.1136/gut.32.2.174 · Cited by 564
Cortisone in Ulcerative Colitis
Truelove, S. C., & Witts, L. J. (1954) · BMJ · doi:10.1136/bmj.2.4884.375 · Cited by 538
Murch, S. H., Braegger, C. P., Walker-Smith, J. A., & MacDonald, T. T. (1993) · Gut · doi:10.1136/gut.34.12.1705 · Cited by 520
MACDONALD, T. T., HUTCHINGS, P., CHOY, M.-Y., MURCH, S., & COOKE, A. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1990.tb03334.x · Cited by 478
Cited by
Items 201–286 of 286
Crohn's disease: future anti–tumor necrosis factor therapies beyond infliximab
Korzenik, J. R. (2004) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2004.02.009 · Cited by 12
Felwick, R., Dingley, G., Martínez-Nuñez, R. T., Sánchez-Elsner, T., Cummings, F. J. R., & Collins, J. E. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz145 · Cited by 11
Cytokines and Chemokines in Mucosal Homeostasis
Maillard, M. H., & Snapper, S. B. (2010) · Wiley eBooks · doi:10.1002/9781444318418.ch10 · Cited by 16
ZUO, D., Tang, Q., Fan, H., Shou, Z., Liu, X., CAO, D., & ZOU, Z. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.3038 · Cited by 15
Amelioration of experimental colitis by thalidomide.
Kenet, G., Wardi, J., Avni, Y., Aeed, H., Shirin, H., Zaidel, L., Hershkoviz, R., & Bruck, R. (2001) · PubMed · Cited by 11
Cota, D. L., Mishra, S. K., & Shengule, S. A. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05766-z · Cited by 11
Microheterogeneity of acute phase proteins in patients with ulcerative colitis.
Grzymislawski, M. B., Derc, K., Sobieska, M., & Wiktorowicz, K. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i32.5191 · Cited by 10
Mitigation of Colitis with NovaSil Clay Therapy
Zychowski, K. E., Elmore, S. E., Rychlik, K. A., Ly, H. J., Pierezan, F., Isaiah, A., Suchodolski, J. S., Hoffmann, A. R., Romoser, A. A., & Phillips, T. D. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3360-7 · Cited by 11
Abdominal Abscesses and Gastrointestinal Fistulas
Minei, J. P., & Champine, J. G. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00026-3 · Cited by 11
Adamkova, P., Hradická, P., Gancarčíková, S., Kassayová, M., Ambro, Ľ., Bertková, I., Marônek, M., Iannaccone, S. F., & Demečková, V. (2021) · Pathogens · doi:10.3390/pathogens10020152 · Cited by 9
Efficacy of anti-TNF-alpha monoclonal antibodies in inflammatory bowel disease treatment
Reimund, J., Deleporte, Viennot, Dupont, Gilletta, Allaire, & Prevost (2013) · International Journal of Interferon Cytokine and Mediator Research · doi:10.2147/ijicmr.s21705 · Cited by 11
Self-citationNutrition in Inflammatory Bowel Disease
Kelly, D. G. (2007) · Clinical Gastroenterology · doi:10.1007/978-1-59745-320-2_3 · Cited by 9
Wang, J., Sijs, B., Bakker, W., de Haan, L., & Bouwmeester, H. (2023) · Toxicology Letters · doi:10.1016/j.toxlet.2023.06.001 · Cited by 8
Anti-Tumor Necrosis Factor-Alpha (TNF-α) Treatment Strategies in Crohns Disease
Reimund, J., Ratajczyk, J., Sola, B., Justum, A., & Muller, C. D. (2007) · Recent Patents on Inflammation & Allergy Drug Discovery · doi:10.2174/187221307779815093 · Cited by 8
Self-citationMohammed, H. A., Saboor-Yaraghi, A. A., Vahedi, H., Yekaninejad, M. S., Panahi, G., Hemmasi, G., Lakzaei, M., & Mirshafiey, A. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.08.011 · Cited by 12
Retreatment and maintenance therapy with infliximab in fistulizing Crohn' disease
Rodrigo, L., Pérez-Pariente, J. M., Fuentes, D., Cadahía, V., García-Carbonero, A., Niño, P., de Francisco, R., Tojo, R., Moreno, M., & González-Ballina, E. (2004) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082004000800004 · Cited by 8
Inhibidores del factor de necrosis tumoral alfa en la enfermedad inflamatoria intestinal
Casellas, F. (2004) · Medicina Clínica · doi:10.1016/s0025-7753(04)74622-9 · Cited by 8
Diab-Assef, M., Reimund, J., Ezenfis, J., Duclos, B., Kédinger, M., & Foltzer, C. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655202753416894 · Cited by 8
Self-citationProspects of new therapeutic approaches for Crohn's disease
Hodgson, H. J. F. (1999) · The Lancet · doi:10.1016/s0140-6736(98)00304-3 · Cited by 8
Zahirović, A., Zupančič, Š., Verdir, A., Nemec, S., Kralj, S., Snoj, L., & Berlec, A. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1657810 · Cited by 8
Systemic Inflammatory Responses in Ulcerative Colitis Patients and Clostridium difficile Infection
Limsrivilai, J., Rao, K. K., Stidham, R. W., Govani, S. M., Waljee, A. K., Reinink, A. R., Johnson, L. A., Briggs, E., & Higgins, P. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5044-1 · Cited by 7
Altered adrenal chromaffin cell function during experimental colitis
Lukewich, M. K., & Lomax, A. E. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00298.2010 · Cited by 7
Daniel, K., Vitetta, L., & Singh, M. A. F. (2021) · British Journal Of Nutrition · doi:10.1017/s0007114521001999 · Cited by 6
The Gut Microbiome Affects Human Mood and Behavior
Villa, T. G., & Sánchez-Pérez, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-77595-7_22 · Cited by 7
Cytokines and Inflammatory Bowel Disease
de Zoeten, E. F., & Fuss, I. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5061-0_3 · Cited by 8
Bistrian, B. R. (1999) · KARGER eBooks · doi:10.1159/000061777 · Cited by 6
Predicting Therapeutic Response by in vivo Molecular Imaging in Inflammatory Bowel Diseases
Atreya, R. N., & Neurath, M. F. (2016) · Digestive Diseases · doi:10.1159/000445262 · Cited by 6
Loss of NKCC1 Activates the NLRP3 Inflammasome in Intestinal Epithelia
Koumangoye, R. B., Ferdaus, M. Z., Davis, X. D., Bohannon, J. K., & Delpire, E. J. (2025) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2025.101681 · Cited by 5
Bhaswati, R. D. (2015) · Journal of Biotechnology & Biomaterials · doi:10.4172/2155-952x.1000181 · Cited by 6
Ichikawa, N., Yamashita, K., Funakoshi, T., Ichihara, S., Fukai, M., Ogura, M., Kobayashi, N., Zaitsu, M., Yoshida, T., Shibasaki, S., et al. (2015) · Inflammation Research · doi:10.1007/s00011-015-0911-0 · Cited by 5
Ueyama, Y., Tokuhara, K., Miki, H., Nakatake, R., Sakaguchi, T., Nishizawa, M., Kaibori, M., & Okumura, T. (2019) · Journal of Surgical Research · doi:10.1016/j.jss.2019.05.047 · Cited by 5
Fecal sST2 correlates with the disease severity of ulcerative colitis
Jovanović, M., Gajović, N., Jurišević, M., Marković, B. S., Marić, V., Jovanović, M., Arsenijević, N., & Zdravković, N. (2018) · Vojnosanitetski pregled · doi:10.2298/vsp171225026j · Cited by 5
The CD200 Regulates Inflammation in Mice Independently of TNF-α Production
Tonecka, K., Braniewska, A., Pilch, Z., Sas, Z., Skorzynski, M., Manuali, E., & Rygiel, T. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105358 · Cited by 5
McShane, C., O’Connell, F., Kevans, D., & O'Sullivan, J. N. (2026) · Digestive Diseases and Sciences · doi:10.1007/s10620-025-09665-w · Cited by 4
Björner, K., Chen, W., Gannavarapu, V. R., Axling, F., Gulyás, M., Halim, M. A., Webb, D., & Hellström, P. M. (2024) · Upsala Journal of Medical Sciences · doi:10.48101/ujms.v128.10241 · Cited by 4
A review of the link between psychological stress and inflammatory bowel disease exacerbation
Klettner, A. M., Luo, S., Coyle, L. D., & Liu, N. (2025) · Academia Mental Health and Well-Being · doi:10.20935/mhealthwellb7617 · Cited by 7
Mucosal healing effect of nilotinib in indomethacin-induced enterocolitis: A rat model
Hakim, G. D., Soyturk, M., Unlu, M., Ataca, P., Karaman, M., Sagol, O., Borekci, E., & Yilmaz, O. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i44.12576 · Cited by 5
Tumor Necrosis Factor-α Triad: Psoriasis, Cardiovascular Disease, and Depression
Leon, A., Liao, W. J., Gupta, R., Koo, J. Y. M., & Wu, J. J. (2013) · Psoriasis Forum · doi:10.1177/247553031319a00105 · Cited by 4
Gómez‐Florit, M., & Costas, H. (2003) · DAU: Debats d'arquitectura i urbanisme : revista de la Demarcació de Lleida del COAC · Cited by 4
Poullis, A. P., Irwin, A. G., Dearing, M., Gordon, C., Britten, A. J., Heenan, S. D., & Maxwell, J. D. (2006) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200606000-00006 · Cited by 5
Sato, K., Tomioka, M., Akiyama, M., Matsuda, Y., Hara, H., Sasa, H., Kurashima, Y., Inoue, J., Fukuda, S., & Kim, Y. (2025) · iScience · doi:10.1016/j.isci.2025.112934 · Cited by 3
HLA in Gastrointestinal Inflammatory Disorders
Torres, M. I., Palomeque, T., & Lorite, P. (2014) · InTech eBooks · doi:10.5772/57497 · Cited by 3
Feodora, I., Hostettler, N., Bianchi, P., & Brunner, T. (2012) · InTech eBooks · doi:10.5772/52788 · Cited by 3
Edfors, K., Ståhlberg, D., & Söderman, C. (2016) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.12336 · Cited by 3
Efficacy of thalidomide on trinitrobenzene sulfonate-induced colitis in young rats and its mechanism
Xu, J., Zheng, C., Huang, Y., & Liang, Y. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20133290 · Cited by 3
Therapeutic Potential of Infliximab in Inflammatory Bowel Disease
Hurd, L. B., & Lichtenstein, G. R. (1999) · Gastroenterology Nursing · doi:10.1097/00001610-199909000-00003 · Cited by 2
Biotechnological Approaches for the Treatment of Inflammatory Diseases
Iansante, V., Capece, D., Murgo, S., Mancarelli, M. M., Zazzeroni, F., & Alesse, E. (2009) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/187152309787580793 · Cited by 3
Cytokines and Inflammatory Bowel Disease
de Zoeten, E. F., & Fuss, I. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-49215-5_3 · Cited by 3
Lagares, C. M. (2015) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/16686 · Cited by 6
Cytokines and Inflammatory Bowel Disease
de Zoeten, E. F., & Fuss, I. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-14744-9_3 · Cited by 3
Zhao, D., Wen, S., Niu, J., Wang, Q., Mi, H., & Liu, F. (2025) · International Journal of Pharmacology · doi:10.3923/ijp.2025.295.316 · Cited by 1
Therapeutic peptides in inflammatory bowel disease
Herrlinger, K. R., Stange, E. F., & Fellermann, K. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.880109 · Cited by 2
Atreya, R. N., Billmeier, U., Räth, T., Neumann, H., & Neurath, M. F. (2015) · Frontiers of gastrointestinal research · doi:10.1159/000381411 · Cited by 1
A case of pyostomatitis vegetans associated with ulcerative colitis.
Namiko, N. A. R. A., Ikebe, T., Kurahara, S., TAKENOSHITA, Y., Nakamura, S., & Shirasuna, K. (2001) · Japanese Journal of Oral & Maxillofacial Surgery · doi:10.5794/jjoms.47.55 · Cited by 1
Colorectal Adenocarcinoma and Inflammatory Bowel Disease: An Update and Review
Karmali, M. L. S. (2015) · Surgery Current Research · doi:10.4172/2161-1076.1000249 · Cited by 1
Elhidaoui, I. (2017) · Journal Africain d Hépato-Gastroentérologie · doi:10.1007/s12157-017-0704-x · Cited by 1
A case of pyostomatitis vegetans associated with ulcerative colitis
Chihiro, I. T. O., Kamatani, T., Akizuki, A., Itose, M., Kondo, S., & Shirota, T. (2016) · Japanese Journal of Oral & Maxillofacial Surgery · doi:10.5794/jjoms.62.608 · Cited by 1
Grossman, J., & Chamow, S. M. (2013) · Wiley eBooks · doi:10.1002/9783527675272.ch10 · Cited by 1
Cytokines and Inflammatory Bowel Disease
de Zoeten, E. F., & Fuss, I. J. (2007) · Springer eBooks · doi:10.1007/978-0-387-73481-1_3 · Cited by 1
Jang, H. N., Bae, U., Jang, M., Lee, S. H., & Kim, G.-C. (2023) · Journal of the Korean Society of Food Science and Nutrition · doi:10.3746/jkfn.2023.52.3.231 · Cited by 1
Biological response modifiers for the treatment of Crohn’s disease
Siveke, J. T., & Folwaczny, C. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.11.1719 · Cited by 1
Immuno-epithelial interactions: Cytokine modulation of normal rabbit colonocyte function
Vidrich, A., Anton, P. A., & Shanahan, F. (1998) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-998-0025-x · Cited by 1
Regulation of Tumor Necrosis Factor-.ALPHA. Production by a Fungal Metabolite, PR 1388.
Ichikawa, K., INAGAKI, T., KOJIMA, Y., Nakamura, T., Nishida, H., UENO, Y., & Kojima, N. (2001) · The Journal of Antibiotics · doi:10.7164/antibiotics.54.977 · Cited by 1
Reimund, J. (1998) · Nutrition Clinique et Métabolisme · doi:10.1016/s0985-0562(98)80098-8 · Cited by 1
Self-citationPharmacotherapy of inflammatory bowel disease: Novel therapeutic approaches
Veljača, M. (2004) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7930-9_2
On the role of the inducible enzymes iNOS and COX-2 in colitis
Kankuri, E. M. (2002) · Helda - University of Helsinki Institutional Repository
Autoimmune Diseases of the Digestive Tract
Prindiville, T. P., & Cantrell, M. C. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-709-3_27
Melchior, C. (2013) · OpenGrey (Institut de l'Information Scientifique et Technique)
Genetic Susceptibility in Inflammatory Bowel Disease
Yamamoto-Furusho, J. K. (2010) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-009-9068-0
Preventive effects of fatty acids and phytochemicals in ApcMin/+ mouse, a model of colorectal cancer
Lima, J. M. A. (2010) · UEA Digital Repository (University of East Anglia)
Raeli, L. (2009) · BOA (University of Milano-Bicocca)
Antibodies to proinflammatory cytokines
Karp, L. C., & Targan, S. R. (2000) · Springer eBooks · doi:10.1007/978-94-011-4002-7_22
Heparins and fucoidans : future therapeutic options for ulcerative colitis
Lean, Q. Y. (2016) · UTAS Research Repository · doi:10.25959/23240687
Prognostische Faktoren des Rektumkarzinoms
Haensch, W., & Slisow, W. (1998) · KARGER eBooks · doi:10.1159/000058605
Yao, A.-J., Chen, J., Yan, X., Zhang, Z., Zou, Z., Yang, H.-T., Hua, Q., Zhao, J., Kang, J.-X., & Zhang, X. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.07.042
Singh, A. (2019) · Journal of International Crisis and Risk Communication Research
Ichikawa, N., Yamashita, K., Funahashi, T., Ichihara, S., Kobayashi, N., Koshizuka, Y., Zaitsu, M., Fukai, M., Suzuki, T., Ozaki, M., et al. (2011) · Gastroenterology · doi:10.1016/s0016-5085(11)62134-3
Data from Blockade of a Chemokine, CCL2, Reduces Chronic Colitis-Associated Carcinogenesis in Mice
Popivanova, B. K., Kostadinova, F. I., Furuichi, K., Shamekh, M. M., Kondo, T., Wada, T., Egashira, K., & Mukaida, N. (2023) · doi:10.1158/0008-5472.c.6499829.v1
Genetically Engineering Microbes for Detecting and Treating Inflammatory Bowel Disease
Dacquay, L. C. (2023) · TSpace (University of Toronto)
Autophagy in the Susceptibility to Crohn's Disease
Foerster, E. G. (2022) · TSpace (University of Toronto)
Intestinal and skin homeostasis : targeting inflammation and cancer
El‐Jamal, N. (2012) · theses.fr (ABES) · doi:10.70675/19534eecz98c4z48b2z92f6z0eb4d568fe93
Boussenna, A. (2015) · theses.fr (ABES) · doi:10.70675/ce17ae02z1188z493az9f7czc7c482b14420 · Cited by 1
Kim, J. Y., Park, B., Riffey, O. F., Bettaieb, A., & Donohoe, D. R. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.11.744327
Hesperetin alleviates DSS induced colitis by inhibiting TLR2/NF-κB and restoring intestinal barrier
Xianpeng, W., Yuzhou, L., Zhan, Y., Taiyu, C., Hongyuan, Z., Yong, W., & Tang, X. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.154504
Serum amyloid a as a high-resolution indicator of mucosal healing in ulcerative colitis
Akita, K., Yokoyama, Y., Shimomori, Y., Kazama, T., Nojima, M., & Nakase, H. (2026) · Crohn s & Colitis 360 · doi:10.1093/crocol/otag097
Metadata
- Authors
- Reimund, J. M., Wittersheim, C., Dumont, S., Muller, C. D., Baumann, R., Poindron, P., & Duclos, B.
- Affiliations
- Hôpital d'Hautepierre (FR)
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- ORCID
- Muller, C. D.
- Venue
- Journal of Clinical Immunology
- Published
- 1996-05
- Volume
- 16
- Issue
- 3
- Pages
- 144-150
- ISSN
- 0271-9142 (ISSN-L)
- 1573-2592
- OpenAlex
- W2047398409
- Cited by
- 281
- References
- 30
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 6 · 2023: 6 · 2022: 4 · 2021: 6 · 2020: 6 · 2019: 8 · 2018: 8 · 2017: 9 · 2016: 10 · 2015: 13 · 2014: 15 · 2013: 10 · 2012: 11
- FWCI
- 4.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Clinical Immunology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- inflammatory bowel disease, ulcerative colitis, Crohn's disease, inflammatory cytokines, TNF-α, IL-1β, interleukin-6, mucosal inflammation, organ culture, lamina propria mononuclear cells, EDTA
- MeSH terms
- Adult, Aged, Colitis, Ulcerative, Crohn Disease, Female, Humans, Interleukin-1, Intestinal Mucosa, Male, Middle Aged, Organ Culture Techniques, Prospective Studies, Tumor Necrosis Factor-alpha, Interleukin-6, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.